Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN)-Reference-Cited by-同舟云学术

Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN)

Published:2017 Issue:3 Volume:2 Page:e000167
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Pedrazzoli Paolo,Silvestris Nicola,Santoro Antonio,Secondino Simona,Brunetti Oronzo,Longo Vito,Mancini Elena,Mariucci Sara,Rampino Teresa,Delfanti Sara,Brugnatelli Silvia,Cinieri Saverio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. Associations between global population health indicators and dialysis variables in the Monitoring Dialysis Outcomes (MONDO) consortium;Calice-Silva;Blood Purif,2015

2. Genomic damage in endstage renal disease-contribution of uremic toxins;Schupp;Toxins,2010

3. Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients;Janus;Ann Oncol,2010

4. [Management of chemotherapy in hemodialysis patients];Janus;Bull Cancer,2012

5. Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study;Janus;Ann Oncol,2013

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Implications of Co‐administering Apixaban with Key Interacting Medications;Clinical Pharmacology in Drug Development;2024-07-24

2. Systemic oncological therapy in breast cancer patients on dialysis;World Journal of Clinical Oncology;2024-06-24

3. The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience;Breast Cancer;2023-12-27

4. Chemotherapy in patients with testicular germ-cell tumors and end-stage renal disease requiring hemodialysis: two case reports;Oncology in Clinical Practice;2023-12-11

5. Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022;Clinical and Experimental Nephrology;2023-10-25